Community Academic Profiles

Paul Heidenreich, MD

Publication Details

  • Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death.

    Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA. Ann Intern Med. 1997; 126 (1): 1-12

    Implantable cardioverter defibrillators (ICDs) are remarkably effective in terminating ventricular arrhythmias, but they are expensive and the extent to which they extend life is unknown. The marginal cost-effectiveness of ICDs relative to amiodarone has not been clearly established.

    PubMedID: 8992917

Stanford Medicine Resources:

Footer Links: